ResearchSafe

N-Acetyl Semax Amidate (N-Acetyl Semax Amidate (NA Semax))

Category: Cognitive & Nootropic. Status: Research compound.

A more stable, longer-acting version of Semax with acetyl and amidate modifications that resist enzymatic breakdown. Used intranasally as a nootropic for focus, BDNF support, and neuroprotection.

How it works

A heptapeptide analog of ACTH(4-10) that increases BDNF and NGF expression, modulates the dopaminergic and serotonergic systems, and provides neuroprotective and pro-focus effects. The acetyl/amidate modifications extend its half-life versus plain Semax.

Key facts

  • Molecular weight: ~900 Da
  • Half-life: Longer than base Semax (modifications resist peptidases)
  • Bioavailability: Intranasal (primary); subcutaneous also used
  • Storage: Refrigerate (2-8°C); keep nasal solutions cold and use within the labeled window.

Dosing overview

  • Typical dose: ~300-600 mcg per day
  • Frequency: 1-2x daily
  • Duration: Cycled (e.g. weeks on/off)
  • Route: Intranasal spray/drops

Protocol notes

  • Common nootropic use is a few hundred mcg intranasally, 1-2x daily.
  • Often dosed in the morning/early afternoon to avoid overstimulation at night.
  • Frequently cycled (e.g. a few weeks on, then a break) and stacked with Selank.

Reported benefits

  • Improved focus and mental clarity
  • Raises BDNF/NGF (neurotrophic)
  • Neuroprotective
  • Longer-acting than base Semax

Possible side effects

  • Nasal irritation
  • Overstimulation/insomnia if dosed late
  • Mild headache (uncommon)

Research

  • Semax and BDNF expression (2016): Semax increased BDNF and related neurotrophic signaling in the hippocampus in animal models.

Compare N-Acetyl Semax Amidate

Research and educational reference only. Not medical advice.